Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-08-26
DOI
10.3389/fneur.2016.00139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia
- (2016) Maryam Nazari et al. BRAIN RESEARCH BULLETIN
- Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic StrokeCLINICAL PERSPECTIVE
- (2015) Zilong Zhu et al. CIRCULATION
- The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
- (2015) Samuel F. Hunter et al. CNS DRUGS
- Protective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage
- (2015) Hao-Liang Xu et al. Journal of Neuroinflammation
- Fingolimod induces neuroprotective factors in human astrocytes
- (2015) Franziska S. Hoffmann et al. Journal of Neuroinflammation
- Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson’s disease and in MPP+-treated MN9D cells in vitro
- (2015) M. Sivasubramanian et al. NEUROSCIENCE
- Sphingosine 1-phosphate signaling at the blood–brain barrier
- (2015) Briana Prager et al. TRENDS IN MOLECULAR MEDICINE
- Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin
- (2015) Claudia Nussbaum et al. Nature Communications
- Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
- (2015) Simona F. Spampinato et al. PLoS One
- Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage
- (2014) Lei Lu et al. BRAIN RESEARCH
- Activation of S1P1 Receptor Regulates PI3K/Akt/FoxO3a Pathway in Response to Oxidative Stress in PC12 Cells
- (2014) Fatemeh Safarian et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory
- (2014) Nitai C Hait et al. NATURE NEUROSCIENCE
- Impact of an immune modulator fingolimod on acute ischemic stroke
- (2014) Ying Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fingolimod for the treatment of neurological diseases—state of play and future perspectives
- (2014) Robert Brunkhorst et al. Frontiers in Cellular Neuroscience
- Fingolimod affects gene expression profile associated with LPS-induced memory impairment
- (2014) Rana Omidbakhsh et al. EXPERIMENTAL BRAIN RESEARCH
- Fingolimod for the Treatment of Intracerebral Hemorrhage
- (2014) Ying Fu et al. JAMA Neurology
- Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine
- (2013) Fatemeh Hemmati et al. BEHAVIOURAL BRAIN RESEARCH
- FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats
- (2013) Masoumeh Asle-Rousta et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients
- (2013) Veronica Tisato et al. MEDIATORS OF INFLAMMATION
- MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke
- (2013) Mayank Chaturvedi et al. MOLECULAR NEUROBIOLOGY
- Fingolimod Therapy for Multiple Sclerosis
- (2013) Mary Willis et al. SEMINARS IN NEUROLOGY
- Fingolimod Reduces Hemorrhagic Transformation Associated With Delayed Tissue Plasminogen Activator Treatment in a Mouse Thromboembolic Model
- (2013) Francisco Campos et al. STROKE
- FTY720 Ameliorates Acute Ischemic Stroke in Mice by Reducing Thrombo-Inflammation but Not by Direct Neuroprotection
- (2013) Peter Kraft et al. STROKE
- Fingolimod attenuates ceramide-induced blood–brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes
- (2012) Ruben van Doorn et al. ACTA NEUROPATHOLOGICA
- Brain-Immune Interactions and Ischemic Stroke
- (2012) Costantino Iadecola ARCHIVES OF NEUROLOGY
- Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature
- (2012) C. Kleinschnitz et al. BLOOD
- Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage
- (2012) William B. Rolland et al. EXPERIMENTAL NEUROLOGY
- The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice
- (2012) Shigetomo Fukuhara et al. JOURNAL OF CLINICAL INVESTIGATION
- Brain-Derived Antigens in Lymphoid Tissue of Patients with Acute Stroke
- (2012) A. M. Planas et al. JOURNAL OF IMMUNOLOGY
- Post-ischemic vascular adhesion protein-1 inhibition provides neuroprotection in a rat temporary middle cerebral artery occlusion model
- (2012) Jittiya Watcharotayangul et al. JOURNAL OF NEUROCHEMISTRY
- Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway
- (2012) Bradley K. Wacker et al. JOURNAL OF NEUROCHEMISTRY
- CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke
- (2012) Ann M Stowe et al. Journal of Neuroinflammation
- The immunology of acute stroke
- (2012) Ángel Chamorro et al. Nature Reviews Neurology
- Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia
- (2011) Waltraud Pfeilschifter et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke
- (2011) Arthur Liesz et al. BRAIN
- Regulatory B Cells Limit CNS Inflammation and Neurologic Deficits in Murine Experimental Stroke
- (2011) X. Ren et al. JOURNAL OF NEUROSCIENCE
- Unknown
- (2011) Constance Finney et al. MOLECULAR MEDICINE
- The immunology of stroke: from mechanisms to translation
- (2011) Costantino Iadecola et al. NATURE MEDICINE
- The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators
- (2011) B. Soliven et al. NEUROLOGY
- FTY720 Reduces Post-Ischemic Brain Lymphocyte Influx but Does Not Improve Outcome in Permanent Murine Cerebral Ischemia
- (2011) Arthur Liesz et al. PLoS One
- Fingolimod provides long-term protection in rodent models of cerebral ischemia
- (2010) Ying Wei et al. ANNALS OF NEUROLOGY
- Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model
- (2010) Fumie Konoeda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions
- (2010) Ruben Van Doorn et al. GLIA
- The Sphingosine 1-Phosphate Transporter, SPNS2, Functions as a Transporter of the Phosphorylated Form of the Immunomodulating Agent FTY720
- (2010) Yu Hisano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics
- (2010) Shobha Thangada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Advances in the management of intracerebral hemorrhage
- (2010) Opeolu Adeoye et al. Nature Reviews Neurology
- Fingolimod is a potential novel therapy for multiple sclerosis
- (2010) Orhan Aktas et al. Nature Reviews Neurology
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetically-Defined Deficiency of Mannose-Binding Lectin Is Associated with Protection after Experimental Stroke in Mice and Outcome in Human Stroke
- (2010) Alvaro Cervera et al. PLoS One
- The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia
- (2009) Bozena Czech et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Monocyte Subtypes Predict Clinical Course and Prognosis in Human Stroke
- (2009) Xabier Urra et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Protective Effects of Early CD4+ T Cell Reduction in Hepatic Ischemia/Reperfusion Injury
- (2009) Mathias Martin et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Synthetic Analogs of FTY720 [2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] Differentially Regulate Pulmonary Vascular Permeability in Vivo and in Vitro
- (2009) S. M. Camp et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
- (2009) N. C. Hait et al. SCIENCE
- Activation of Sphingosine 1-Phosphate Receptor-1 by FTY720 Is Neuroprotective After Ischemic Stroke in Rats
- (2009) Yu Hasegawa et al. STROKE
- FTY720 Rescue Therapy in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis: Expression of Central Nervous System Genes and Reversal of Blood-Brain-Barrier Damage
- (2008) Carolyn A. Foster et al. BRAIN PATHOLOGY
- S1P1 Receptor Signaling Overrides Retention Mediated by Gαi-Coupled Receptors to Promote T Cell Egress
- (2008) Trung H.M. Pham et al. IMMUNITY
- Principles of bioactive lipid signalling: lessons from sphingolipids
- (2008) Yusuf A. Hannun et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More